Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term xenografts. Found 5 abstracts

Nielsen UB, Adams GP, Weiner LM, Marks JD. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity. Cancer Research. 2000 Nov 15;60(22):6434-40.
Stevenson JP, DeMaria D, Sludden J, Kaye SB, Paz-Ares L, Grochow LB, McDonald A, Selinger K, Wissel P, O'Dwyer PJ, Twelves C. Phase I pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion. Annals of Oncology. 1999 Mar;10(3):339-44.
Stevenson JP, Scher RM, Kosierowski R, Fox SC, Simmonds M, Yao KS, Green F, Broom C, Fields SZ, Krebs JB, O'Dwyer PJ. Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas. European Journal of Cancer. 1998 Aug;34(9):1358-62.
Franks SE, Kuesel AC, Lutz NW, Hull WE. P-31 MRS of human tumor cells: Effects of culture media and conditions on phospholipid metabolite concentrations. Anticancer research. 1996 May;16(3B):1365-74.
Adams GP, McCartney JE, Tai MS, Oppermann H, Huston JS, Stafford WF, Bookman MA, Fand I, Houston LL, Weiner LM. Highly Specific in-Vivo Tumor Targeting by Monovalent and Divalent Forms of 741f8 Anti-C-Erbb-2 Single-Chain Fv. Cancer Research. 1993 Sep;53(17):4026-34.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term xenografts

Last updated on Thursday, April 02, 2020